NICOX (EPA:COX) | Finanzwire

Basculer en Français

9773	Companies
195566	Keywords
126551	Articles
103964	Press releases

Home
Companies
NICOX

BRIEF

published on 05/27/2025 at 07:35, 8 months 2 days ago

Nicox secures up to €3 million from Kowa to advance NCX 470

Ocular Hypertension Phase 3 Nicox NCX 470 Kowa
BRIEF

published on 05/14/2025 at 07:35, 8 months 15 days ago

Nicox Reports Findings from Whistler Phase 3b Glaucoma Trial

Glaucoma Nicox NCX 470 Whistler Phase 3b Intraocular Pressure
PRESS RELEASE

published on 05/14/2025 at 07:30, 8 months 15 days ago

Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial
Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial

Nicox NCX 470 Glaucoma Trial Whistler Phase 3b Intraocular Pressure
BRIEF

published on 04/30/2025 at 07:35, 8 months 29 days ago

Nicox Reports Full Year 2024 Financials

Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
PRESS RELEASE

published on 04/30/2025 at 07:30, 8 months 29 days ago

Nicox Provides Full Year 2024 Financial Results
Nicox reports €7.9 million revenue for 2024 with exceptional income of €13.7 million from VYZULTA transfer. Cash of €10.5 million and NCX 470 Phase 3 trial results expected in Q3 2025

Financial Results Revenue Nicox NCX 470 VYZULTA
BRIEF

published on 03/19/2025 at 07:35, 10 months 10 days ago

Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial

Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
PRESS RELEASE

published on 03/19/2025 at 07:30, 10 months 10 days ago

Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025

Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
BRIEF

published on 01/28/2025 at 07:35, 1 year ago

Nicox: Participation in Major Congresses in 2025

Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE

published on 01/28/2025 at 07:30, 1 year ago

Nicox Announces Scientific Presentation and Conference Attendance in H1 2025
Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025

Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF

published on 01/22/2025 at 07:35, 1 year ago

Nicox maintains its eligibility for the PEA-PME

PEA-PME Euronext Investment Ophthalmology Nicox

Accesswire

Published on 01/30/2026 at 00:00, 1 hour 41 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 2 hours 41 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 6 hours 56 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 7 hours 41 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/29/2026 at 17:00, 8 hours 41 minutes ago

Sparta Reports on Delay in Filing Annual Financial Statements

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 00:07, 1 hour 33 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 4 hours 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 4 hours 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 20:59, 4 hours 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 4 hours 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 01/29/2026 at 18:00, 7 hours 41 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 7 hours 56 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 7 hours 56 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 8 hours 1 minute ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 15 hours 33 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE